Your Subtitle text

Management

Subba R Katamreddy, Ph.D. (K.S.Reddy), the founder and president of V-PHARMA, has over 16 years of synthetic organic chemistry and preclinical drug discovery experience in both academia and the pharmaceutical industry. Dr. K.S.Reddy earned his Ph.D. in Chemistry in 1995 at the Pondicherry University, Pondicherry, India; and then over the next five years completed his postdoctoral studies at the University of Hyderabad, India; the University of Barcelona, Spain; and the Emory University in Atlanta, GA, USA. He then joined GlaxoSmithKline as a principal scientist in the department of medicinal chemistry in 2001, and progressed to be named and served as a Research Investigator. Later, in 2009, he founded V-PHARMA.

Dr. K.S. Reddy has worked in preclinical drug discovery programs with multidisciplinary teams consisting of representatives from Chemistry, Biology, Pharmacology, Cheminformatics, and Legal. He has experience in working on multiple target classes such as nuclear receptors (NRs), Opioids, and GPCR’s. Dr. K.S.Reddy developed a significant expertise in discovering high quality clinical candidates through integration of currently available drug discovery principles/tools and addressed the complex developmental issues such as solubility, bioavailability and securing intellectual property rights. This effort ultimately helped in identifying two phase II clinical assets.

He is a co-inventor of 12 patents/patent applications and co-authored 26 research articles published in peer-reviewed journals. He is the recipient of several fellowships and awards; including the Junior and Senior Research Fellowships from UGC, India, Research Associate ships from CSIR, India, and Spain. He won GlaxoSmithKline R&D’s Exceptional Science Award in 2007 for his creative work on GPR119 agonist drug discovery program (to treat metabolic disorders including Type-2 diabetes).

Dr. K.S.Reddy is a member of the American Chemical Society (ACS), ACS Medicinal Chemistry, the America Diabetes Association (ADA), and the New York Academy of Sciences (NYAS).

Selected publications and Patents:
Coming soon.

LinkedIn
Web Hosting